Showing 2031 - 2040 of 3132 for "Technology and telecommunications" with applied filters
16 January 2024 by Manisha Singh (Partner) & Vaneet Kaur (Managing Associate)
The exclusive right of a patentee to stop others from making or using their invention for a defined period is balanced by the obligation to disclose the invention in detail.
08 January 2024 by AnJie Broad Law Firm
RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH
05 January 2024 by Ray SHI, Claire XU
Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).
04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
03 January 2024 by Hui Ye Law Firm - China
Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises
03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU
ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China
03 January 2024 by Hui Ye Law Firm - China
Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.
02 January 2024 by Manisha Singh (Partner) & Avi Garg (Partner)
Non-patentable inventions are always a bone of contention between the applicant and the patent office.
02 January 2024 by Lee & Ko - South Korea
On December 19, 2023, the Korea Fair Trade Commission (“KFTC”) announced its proposal to enact the “Platform Competition Promotion Act” (“PCPA”) for ex-ante regulation of platforms by designating “dominant platform operators.”
21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)
The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits
Register for FREE and enjoy the following benefits:
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
